History
Codeine is an alkaloid found in opium and other
poppy saps like Papaver bracteatum, the Iranian
poppy, in concentrations ranging from 0.3 to 3.0
percent. While codeine can be extracted from opium,
most codeine is synthesized from morphine through
the process of O-methylation. It was first isolated
in 1830 in France by Jean-Pierre Robiquet.
The effects of the Nixon War On Drugs by 1972 or so
had caused across-the-board shortages of illicit and
licit opiates because of a scarcity of natural
opium, poppy straw and other sources of opium
alkaloids, and the geopolitical situation was
getting less helpful for the United States. After a
large percentage of the opium and morphine in the US
National Stockpile of Strategic & Critical Materials
had to be tapped in order to ease severe shortages
of medicinal opiates -- the codeine-based
antitussives in particular -- in late 1973,
researchers were tasked with and quickly succeeded
in finding a way to synthesize codeine and its
derivatives and precursors from scratch from
petroleum or coal tar using a process developed at
the United States' National Institutes of Health.
Numerous codeine salts have been prepared since the
drug was discovered. The most commonly used are the
hydrochloride (freebase conversion ratio 0.805),
phosphate (0.736), sulphate (0.859) and citrate
(0.842). Others include a salicylate NSAID, codeine
salicylate (0.686), and at least four codeine-based
barbiturates, the cyclohexenylethylbarbiturate
(0.559), cyclopentenylallylbarbiturate (0.561),
diallylbarbiturate (0.561), and diethylbarbiturate
(0.619).
Pharmacology
Codeine is considered a prodrug, since it is
metabolised in vivo to the primary active compounds
morphine and codeine-6-glucuronide.[2][3] Roughly
5-10% of codeine will be converted to morphine, with
the remainder either free, conjugated to form
codeine-6-glucuronide (~70%), or converted to
norcodeine (~10%) and hydromorphone (~1%). It is
less potent than morphine and has a correspondingly
lower dependence-liability than morphine.[4] Like
all opioids, continued use of codeine induces
physical dependence and can be psychologically
addictive. However, the withdrawal symptoms are
relatively mild and as a consequence codeine is
considerably less addictive than the other opiates.
A dose of approximately 200 mg (oral) of codeine
must be administered to give analgesia approximately
equivalent to 30 mg (oral) of morphine (Rossi,
2004). However, codeine is generally not used in
single doses of greater than 60 mg (and no more than
240 mg in 24 hours)[5]. When analgesia beyond this
is required, stronger opioids such as hydrocodone or
oxycodone are favored. Because codeine needs to be
metabolized to an active form, there is a ceiling
effect around 400-450 mg. This low ceiling further
contributes to codeine being less addictive than the
other opiates. The ceiling dose can be more
accurately calculated by using 7 mg per 1 kg of
bodyweight for males and 6 mg per 1 kg of bodyweight
for females, taking into consideration an 18.5-25
BMI bodyweight to not over or under calculate in
cases of obese or underweight people (this rule does
not take into consideration the usage of other
CYP2D6 inhibiting drugs, alcohol or naturally low or
high enzyme presence though a 25% enzyme occupancy
reduction can prove more accurate results). Example:
A 85kg male, bearing a height of 180cm is 5kg
overweight, therefore the ceiling dose can be
calculated by 7mg x (85-5)kg = 560mg and for a
female of the same height and weight, 6mg x (85-5)kg
= 480mg. 25% reduction to consider momentary enzyme
occupancy, (560x0.75) putting the ceiling limit at
420mg. Total CYP2D6 saturation or exceeding the
ceiling dose often results in excessive histamine
release to combat the yet to be processed codeine
which results in swelling of bodily areas such as
the genitals, cheeks, hands and feet often mimicking
an adverse or allergic reaction despite subsidence
with time.
Indications
Approved indications for
codeine include:
Cough, though its efficacy in low dose over the
counter formulations has been disputed.[8]
Diarrhea
Mild to severe pain
Irritable bowel syndrome
Codeine is sometimes marketed in combination
preparations with the analgesic acetaminophen (paracetamol),
as co-codamol, paracod, panadeine, or Tylenol 3;
with the analgesic acetylsalicylic acid (aspirin),
as co-codaprin; or with the NSAID (non-steroidal
anti-inflammatory drug) ibuprofen, as Nurofen Plus.
These combinations provide greater pain relief than
either agent alone (drug synergy). Codeine is also
commonly compounded with other pain killers or
muscle relaxers such as Fioricet with Codeine, Soma
Compound/Codeine, etc. Codeine-only products can be
obtained with a prescription as a time release
tablet (e.g. Codeine Contin(r) 100 mg and Perduretas
50 mg).
The narcotic content number in the US names of
codeine tablets and combination products like
Tylenol With Codeine No. 3, Emprin With Codeine No.
4 are as follows: No. 1 - 7½ or 8 mg (1/8 grain),
No. 2 - 15 or 16 mg (1/4 grain), No. 3 - 30 or 32 mg
(1/2 grain), No. 4 - 60 or 64 mg (1 grain). The
Canadian 222 series is identical to the above list
222=1/8 grain, 292=1/4 grain, 293=1/2 grain, and
294=1 grain of codeine.
Injectable codeine is available for subcutaneous or
intramuscular injection; intravenous injection can
cause a serious reaction which can progress to
anaphylaxis. Codeine suppositories are also marketed
in some countries.
Availability
Codeine phosphate and sulphate are marketed in the
United States and Canada. Codeine hydrochloride is
more commonly marketed in continental Europe and
other regions, and codeine hydroiodide and codeine
citrate round out the top five most-used codeine
salts worldwide. Codeine is usually present in raw
opium as free alkaloid in addition to codeine
meconate, codeine pectinate, and possibly other
naturally-occurring codeine salts. Codeine
bitartrate, tartrate, nitrate, picrate, acetate,
hydrobromide and others are occasionally encountered
on the pharmaceutical market and in research.
In certain jurisdictions, codeine is available
over-the-counter in combination with guaifenesin or
promethazine to be sold at the pharmacist's
discretion, though many pharmacists decline to do
so[citation needed].
Relation
to other opiates
Codeine is the starting material and prototype of a
large class of mainly mild to moderately strong
opioids such as hydrocodone, dihydrocodeine and its
derivatives such as nicocodeine. Other series of
codeine derivatives include isocodeine and its
derivatives, which were developed in Germany
starting around 1920. Related to codeine in other
ways are Codeine-N-Oxide (Genocodeine), related to
the nitrogen morphine derivatives as is codeine
methobromide, and heterocodeine which is a drug six
times stronger than morphine and 72 times stronger
than codeine due to a small re-arrangement of the
molecule, viz. moving the methyl group from the 3 to
the 6 position on the morphine carbon skeleton.
Drugs bearing resemblance to codeine in effects due
to close structural relationship are variations on
the methyl groups at the 3 position including
ethylmorphine a.k.a. codethyline (Dionine) and
benzylmorphine (Peronine). While having no narcotic
effects of its own, the important opioid precursor
thebaine differs from codeine only slightly in
structure. Pseudocodeine and some other similar
alkaloids not currently used in medicine are found
in trace amounts in opium as well.
Adverse
effects
Common effects other than analgesia associated with
the use of codeine include euphoria, itching,
nausea, vomiting, drowsiness, dry mouth, miosis,
orthostatic hypotension, urinary retention,
depression and constipation.[9] Another side effect
commonly noticed is the lack of sexual drive and
increased complications in erectile dysfunction.[10]
Some people may also have an allergic reaction to
codeine, such as the swelling of skin and
rashes.[10]
Tolerance to many of the effects of codeine develops
with prolonged use, including therapeutic effects.
The rate at which this occurs develops at different
rates for different effects, with tolerance to the
constipation-inducing effects developing
particularly slowly for instance.
A potentially serious adverse drug reaction, as with
other opioids, is respiratory depression. This
depression is dose-related and is the mechanism for
the potentially fatal consequences of overdose. As
codeine is metabolized to morphine, morphine can be
passed through breast milk in potentially lethal
amounts, fatally depressing the respiration of a
breastfed baby.[11]
Withdrawal
effects
As with other opiate-based pain killers, chronic use
of codeine can cause physical dependence. When
physical dependence has developed, withdrawal
symptoms may occur if a person suddenly stops the
medication. Withdrawal symptoms include: drug
craving, runny nose, yawning, sweating, insomnia,
weakness, stomach cramps, nausea, vomiting,
diarrhea, muscle spasms, chills, irritability and
pain. To minimize withdrawal symptoms, long-term
users should gradually reduce their codeine
medication under the supervision of a healthcare
professional.[12] A support group called CodeineFree
exists to help people who have found themselves
dependent on codeine.
Recreational use
Codeine can be used as a recreational drug. However,
it has much less abuse potential than some other
opiates or opioids, such as oxycodone and
hydrocodone.
In some countries, cough syrups and tablets
containing codeine are available without
prescription; some potential recreational users are
reported to buy codeine from multiple pharmacies so
as not to arouse suspicion. A heroin addict may use
codeine to ward off the effects of a withdrawal.[13]
Codeine is also available in conjunction with the
anti-nausea medication promethazine in the form of a
syrup. Brand named as Phenergan with Codeine or
generically as promethazine with codeine this
medication is quickly becoming one of the most
highly abused codeine preparations.[14]
Codeine is also demethylated by reaction with
pyridine to illicitly synthesize morphine. Pyridine
is toxic and possibly carcinogenic, so morphine
illicitly produced in this manner (and potentially
contaminated with pyridine) may be particularly
harmful.[15] Codeine can also be turned into α-chlorodide
which is used in the clandestine synthesis of
desomorphine (Permonid®). Codeine can also be turned
directly into stronger derivatives of the
dihydrocodeine and hydrocodone families and a few
others with various chemicals and equipment.
Controlled
substance
In Australia, New Zealand, The United Kingdom,
Romania, Canada and many other countries, codeine is
regulated. In some countries it is available without
prescription in combination preparations from
licensed pharmacists in doses up to 15 mg/tablet in
Australia, New Zealand, Poland (Thiocodin) and Costa
Rica, 12.8 mg/tablet in the United Kingdom, 10
mg/tablet in Israel and 8 mg/tablet in Canada and
Estonia.[citation needed]
External
Links
-
Shen H, He MM, Liu H, et al (August 2007). "Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17". Drug Metab. Dispos. 35 (8): 1292–300. doi:. PMID 17470523.
-
Vree TB, van Dongen RT, Koopman-Kimenai PM (2000). "Codeine analgesia is due to codeine-6-glucuronide, not morphine". Int. J. Clin. Practa. 54 (6): 395–8. PMID 11092114.
-
Srinivasan V, Wielbo D, Tebbett IR (1997). "Analgesic effects of codeine-6-glucuronide after intravenous administration". European journal of pain (London, England) 1 (3): 185–90. doi:. PMID 15102399.
-
Vree TB, van Dongen RT, Koopman-Kimenai PM (2000). "Codeine analgesia is due to codeine-6-glucuronide, not morphine". Int. J. Clin. Pract. 54 (6): 395–8. PMID 11092114.
-
http://www.sdrl.com/druglist/codeine.html retrieved December 1, 2008
-
Codeine Information - Facts - Codeine". http://codeine.50g.com/info/codeine.html. Retrieved on 2007-07-16.
-
Srinivasan V, Wielbo D, Tebbett IR (1997). "Analgesic effects of codeine-6-glucuronide after intravenous administration". European journal of pain (London, England) 1 (3): 185–90. doi:. PMID 15102399.
-
Schroeder K, Fahey T (2001). "Over-the-counter medications for acute cough in children and adults in ambulatory settings". Cochrane Database Syst Rev: CD001831. doi:. PMID 15495019.
-
Australian Medicines Handbook (2004). Rossi S. ed. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook. ISBN 0975791923. OCLC 224831213 224913182.
-
CTV News, Codeine use while breastfeeding may be dangerous, Wed. Aug. 20 2008 9:42 PM ET. Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 2006; 368: 704.
-
Alberta Health Services; AADAC (April 16, 2007). "The ABCs - Codeine and Other Opioid Painkillers". Alberta Alcohol and Drug Abuse Commission. http://www.aadac.com/87_436.asp. Retrieved on Sep 12 2008.
-
Boekhout van Solinge, Tim. "7. La politique de soins des années quatre-vingt-dix" (in French). L'héroïne, la cocaïne et le crack en France. Trafic, usage et politique. Amsterdam: CEDRO Centrum voor Drugsonderzoek, Universiteit van Amsterdam. pp. 247–262.
-
Leinwand, Donna (2006-10-18). "DEA warns of soft drink-cough syrup mix". USA Today. http://www.usatoday.com/news/nation/2006-10-18-lean_x.htm?csp=34. Retrieved on 2006-10-23.
-
Hogshire, Jim (June 1999). Pills-A-Go-Go: A Fiendish Investigation into Pill Marketing, Art, History & Consumption. Los Angeles: Feral House. pp. 216–223. ISBN 0922915539.
-
"Headache Triggers: Caffeine". WebMD. June 2004. http://www.webmd.com/content/article/46/1826_50681.htm. Retrieved on 2007-03-23.
-
International Narcotics Control Board. "List of Narcotic Drugs under International Control" (PDF). http://www.incb.org/pdf/e/list/46thedition.pdf. Retrieved on 2006-05-24





